Ophthalmology · Bonita Springs, FL
NPI
1619137320
Since 2008
Specialty
Ophthalmology
Code 207W00000X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
28901 Trails Edge Blvd Ste 202
Bonita Springs, FL, 34134
Phone (239) 544-3122
Groups this clinician bills Medicare through
Medicare paid, 2024
$770K
14,492 services
Medicare patients, 2024
1,046
Average age 79
Drug cost, 2024
$2.7M
1,844 prescriptions
Company payments, 2025
$162K
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Carl J Danzig was code J2777 (injection, faricimab-svoa, 0.1 mg), 6,240 times for 54 patients. In total Carl J Danzig billed 14,492 services in 45 codes, and Medicare paid $770K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-12-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2777 Injection, faricimab-svoa, 0.1 mg | Office | 6,240 | 54 | $27.23 | $170K |
| 92134 Computerized Ophthalmic Imaging | Office | 2,171 | 971 | $31.01 | $67K |
| 67028 Intravitreal Injection | Office | 1,119 | 262 | $103.03 | $115K |
| 92250 Angiography | Office | 938 | 778 | $29.13 | $27K |
| 92012 Ophthalmological E&M | Office | 840 | 381 | $68.73 | $58K |
| J3490 Unclassified drugs | Office | 837 | 226 | $79.91 | $67K |
| 92014 Ophthalmological E&M | Office | 796 | 707 | $94.02 | $75K |
| J2782 Injection, avacincaptad pegol, 0.1 mg | Office | 660 | 12 | $86.37 | $57K |
| J0177 Injection, aflibercept hd, 1 mg | Office | 248 | 15 | $262.48 | $65K |
| 92004 Ophthalmological E&M | Office | 102 | 102 | $95.25 | $9,716 |
| 92201 Ophthalmological E&M | Office | 67 | 52 | $19.34 | $1,296 |
| 92202 Ophthalmological E&M | Office | 61 | 61 | $11.72 | $715 |
| 92083 Vision, Hearing, and Speech Services | Office | 45 | 43 | $51.47 | $2,316 |
| 76512 Ultrasound - Nonspecific | Office | 32 | 27 | $44.68 | $1,430 |
| 92235 Angiography | Office | 18 | 16 | $124.43 | $2,240 |
By year: 2022 $1.4M for 10,851 services; 2023 $851K for 13,695 services; 2024 $770K for 14,492 services.
Medicare prescription drug claims, 2024
In 2024, the drug Carl J Danzig prescribed most often to Medicare patients was Vabysmo (Faricimab-Svoa), with 452 prescriptions and refills. In total Carl J Danzig wrote 1,844 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Vabysmo Faricimab-Svoa | 452 | 489 | 92 | $1.4M |
| Latanoprost Generic | 253 | 402 | 78 | $2,105 |
| Eylea Aflibercept | 167 | 195 | 49 | $452K |
| Brimonidine Tartrate Generic | 116 | 172 | 33 | $2,801 |
| Izervay Avacincaptad Pegol Sodium/Pf | 100 | 101 | 16 | $241K |
| Eylea Hd Aflibercept | 99 | 142 | 28 | $403K |
| Ketorolac Tromethamine Generic | 86 | 87 | 31 | $2,160 |
| Prednisolone Acetate Generic | 85 | 99 | 43 | $3,196 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 75 | 154 | 29 | $1,144 |
| Dorzolamide Hcl Generic | 41 | 78 | 16 | $572 |
| Ofloxacin Generic | 37 | 38 | 30 | $405 |
| Combigan Brimonidine Tartrate/Timolol | 32 | 46 | Under 11 | $11K |
| Rocklatan Netarsudil Mesylat/Latanoprost | 32 | 47 | Under 11 | $12K |
| Difluprednate Generic | 23 | 23 | Under 11 | $2,202 |
| Prolensa Bromfenac Sodium | 21 | 33 | Under 11 | $8,142 |
Brand drugs: 1,268 claims; generic drugs: 576 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Carl J Danzig $162K ($150K in general payments such as food, travel and fees and $12K for research) from 19 companies. The largest payer was Astellas Pharma US Inc with $92K.
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc 4503.T | 61 | $92K |
| Ocular Therapeutix, Inc. OCUL | 47 | $46K |
| Genentech USA, Inc. ROG.SW | 11 | $9,196 |
| Astellas Pharma Global Development 4503.T | 5 | $5,155 |
| Apellis Pharmaceuticals, Inc. APLS | 6 | $3,344 |
| F. Hoffmann-La Roche AG ROG.SW | 4 | $2,659 |
| Genentech, Inc. ROG.SW | 3 | $1,708 |
| Abbvie Inc. ABBV | 3 | $1,227 |
| Samsung Bioepis Co., Ltd. | 1 | $713 |
| Harrow Eye, LLC | 4 | $343 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.